MEK inhibitor therapy in carcinomas with RAF1 fusions: Inferior response in a patient with pancreatic acinar cell carcinoma

CR McEvoy; D Kee; OWJ Prall; TD Clay; C Scott; A Backhouse; SB Fox; AP Fellowes; H Xu

Journal article

MEK inhibitor therapy in carcinomas with RAF1 fusions: Inferior response in a patient with pancreatic acinar cell carcinoma

CR McEvoy, D Kee, OWJ Prall, TD Clay, C Scott, A Backhouse, SB Fox, AP Fellowes, H Xu

JCO Precision Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2019

DOI: 10.1200/PO.19.00159

University of Melbourne Researchers

Related Projects (1)

PREPARING AUSTRALIA FOR GENOMIC MEDICINE: A PROPOSAL BY THE AUSTRALIAN GENOMICS HEALTH ALLIANCE

The sequencing of the human genome brings the possibility of more accurate identification of the underlying basis of many diseases. This tec..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

Supported by Melbourne Genomic Health Alliances and the Australian Genomic Health Alliance (National Health and Medical Research Council Grant No.1113531) and the Stafford Fox Medical Research Foundation for funding the Genomic Matching Treatment for Rare Cancers (NOMINATOR) study.